As of May 29, 2025, Pluristem Therapeutics Inc (PSTI) reports a Current Ratio of 5.85.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Pluristem Therapeutics Inc's Current Ratio
Over recent years, Pluristem Therapeutics Inc's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2021-06-30 | 5.85 |
| 2020-06-30 | 6.07 |
| 2019-06-30 | 3.23 |
| 2018-06-30 | 3.75 |
| 2017-06-30 | 5.36 |
This slight downward trend highlights how Pluristem Therapeutics Inc manages its short-term assets and liabilities over time.
Comparing Pluristem Therapeutics Inc's Current Ratio to Peers
To better understand Pluristem Therapeutics Inc's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Pluristem Therapeutics Inc (PSTI) | 5.85 |
| Protara Therapeutics Inc (TARA) | 15.71 |
| Atossa Therapeutics Inc (ATOS) | 14.99 |
| Galecto Inc (GLTO) | 14.07 |
| DiaMedica Therapeutics Inc (DMAC) | 8.28 |
| Aeterna Zentaris Inc (AEZS.TO) | 8.01 |
Compared to its competitors, Pluristem Therapeutics Inc's Current Ratio is about average compared to peers, reflecting balanced short-term asset management.